Virtus ETF Advisers LLC Crispr Therapeutics Ag Transaction History

Virtus ETF Advisers LLC

  • $234 Million
  • Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 7,702 shares of CRSP stock, worth $317,091. This represents 0.13% of its overall portfolio holdings.

Number of Shares
7,702
Previous 5,047 52.61%
Holding current value
$317,091
Previous $237,000 27.85%
% of portfolio
0.13%
Previous 0.12%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$38.65 - $55.15 $102,615 - $146,423
2,655 Added 52.61%
7,702 $303,000
Q2 2024

Aug 14, 2024
SELL
$51.17 - $68.18 $51,528 - $68,657
-1,007 Reduced 16.63%
5,047 $272,000
Q1 2024

May 15, 2024
BUY
$60.67 - $89.12 $52,843 - $77,623
871 Added 16.8%
6,054 $412,000
Q4 2023

Feb 15, 2024
BUY
$38.62 - $72.18 $135,247 - $252,774
3,502 Added 208.33%
5,183 $324,000
Q3 2023

Nov 07, 2023
SELL
$45.39 - $59.0 $7,398 - $9,617
-163 Reduced 8.84%
1,681 $76,000
Q2 2023

Aug 14, 2023
SELL
$43.47 - $67.77 $7,520 - $11,724
-173 Reduced 8.58%
1,844 $103,000
Q1 2023

May 15, 2023
SELL
$41.0 - $56.12 $31,734 - $43,436
-774 Reduced 27.73%
2,017 $91,000
Q4 2022

Feb 14, 2023
BUY
$39.19 - $65.67 $39,033 - $65,407
996 Added 55.49%
2,791 $113,000
Q3 2022

Nov 14, 2022
BUY
$61.1 - $83.78 $672 - $921
11 Added 0.62%
1,795 $117,000
Q2 2022

Aug 12, 2022
SELL
$43.23 - $73.83 $12,839 - $21,927
-297 Reduced 14.27%
1,784 $108,000
Q1 2022

May 16, 2022
SELL
$53.19 - $79.24 $6,489 - $9,667
-122 Reduced 5.54%
2,081 $131,000
Q4 2021

Feb 14, 2022
BUY
$70.09 - $111.29 $39,180 - $62,211
559 Added 34.0%
2,203 $167,000
Q3 2021

Nov 15, 2021
SELL
$110.2 - $156.64 $10,248 - $14,567
-93 Reduced 5.35%
1,644 $184,000
Q2 2021

Aug 10, 2021
SELL
$100.84 - $161.89 $26,823 - $43,062
-266 Reduced 13.28%
1,737 $281,000
Q1 2021

May 17, 2021
BUY
$110.72 - $210.04 $4,096 - $7,771
37 Added 1.88%
2,003 $244,000
Q4 2020

Feb 12, 2021
SELL
$79.67 - $173.23 $254,067 - $552,430
-3,189 Reduced 61.86%
1,966 $301,000
Q3 2020

Nov 13, 2020
SELL
$78.5 - $100.64 $54,086 - $69,340
-689 Reduced 11.79%
5,155 $431,000
Q2 2020

Aug 05, 2020
BUY
$38.5 - $76.05 $13,359 - $26,389
347 Added 6.31%
5,844 $429,000
Q1 2020

May 14, 2020
SELL
$33.68 - $62.53 $27,247 - $50,586
-809 Reduced 12.83%
5,497 $233,000
Q4 2019

Feb 13, 2020
BUY
$36.68 - $73.13 $231,304 - $461,157
6,306 New
6,306 $384,000

Others Institutions Holding CRSP

# of Institutions
488
Shares Held
64.1M
Call Options Held
1.64M
Put Options Held
1.93M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.21B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email